# A Registry Study Evaluating Outcomes in Breast Biopsy With the Intact™ Breast Lesion Excision System (BLES)

> **NCT03520127** · — · TERMINATED · sponsor: **Medtronic Surgical Technologies** · enrollment: 176 (actual)

## Conditions studied

- Breast Lesions

## Interventions

- **DEVICE:** Intact Breast Lesion Excision System (BLES)

## Key facts

- **NCT ID:** NCT03520127
- **Lead sponsor:** Medtronic Surgical Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-09-27
- **Primary completion:** 2019-02-15
- **Final completion:** 2019-02-28
- **Target enrollment:** 176 (ACTUAL)
- **Why stopped:** Product withdrawn from the market due to a shift in sponsor business focus
- **Last updated:** 2019-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03520127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03520127, "A Registry Study Evaluating Outcomes in Breast Biopsy With the Intact™ Breast Lesion Excision System (BLES)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03520127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*